SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Aleksandra Podlecka-Piętowska, Janusz Kochanowski, Beata Zakrzewska-Pniewska, Grzegorz Opolski, Hubert Kwieciński, Anna Maria Kamińska, The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients, Neurologia i Neurochirurgia Polska, 2014, 48, 2, 111

    CrossRef

  2. 2
    Ivan Adamec, Ivo Bach, Anabella Karla Barušić, Antonija Mišmaš, Mario Habek, Assessment of prevalence and pathological response to orthostatic provocation in patients with multiple sclerosis, Journal of the Neurological Sciences, 2013, 324, 1-2, 80

    CrossRef

  3. 3
    Francesca Bagnato, Diego Centonze, Simonetta Galgani, Maria Grazia Grasso, Shalom Haggiag, Stefano Strano, Painful and involuntary multiple sclerosis, Expert Opinion on Pharmacotherapy, 2011, 12, 5, 763

    CrossRef

  4. 4
    Mauro Toniolo, Corinna Bergamini, Valeria Ferrero, Giorgio Morando, Mariantonietta Cicoira, Corrado Vassanelli, Severe acute left ventricular dysfunction in multiple sclerosis, Journal of Cardiovascular Medicine, 2011, 12, 7, 501

    CrossRef

  5. 5
    Richard E Gonsette, Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis, Expert Opinion on Pharmacotherapy, 2007, 8, 8, 1103

    CrossRef

  6. 6
    William P. Santamore, Nurit Gefen, Aharon Avramovich, Philip Berger, Abul Kashem, Ofer Barnea, Right Atrial Effects on Right Ventricular Ejection Fraction Derived From Thermodilution Measurements, Journal of Cardiothoracic and Vascular Anesthesia, 2007, 21, 5, 644

    CrossRef

  7. 7
    Nir Uriel, Edo Kaluski, Alberto Hendler, Marina Leitman, Zvi Vered, Cardiogenic shock in a young female with multiple sclerosis, Resuscitation, 2006, 70, 1, 153

    CrossRef

  8. 8
    Edward J. Fox, Management of worsening multiple sclerosis with mitoxantrone: A review, Clinical Therapeutics, 2006, 28, 4, 461

    CrossRef

  9. 9
    Ferit Akgül, İsmet Mclek, Taşkın Duman, Ergün Seyfelì, Tunzale Seydaliyeva, Fatih Yalçın, Subclinical left ventricular dysfunction in multiple sclerosis, Acta Neurologica Scandinavica, 2006, 114, 2
  10. 10
    McAlpine's Multiple Sclerosis, 2006,

    CrossRef

  11. 11
    S. Goffette, V. Pesch, J. L. Vanoverschelde, E. Morandini, C. J. M. Sindic, Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone, Journal of Neurology, 2005, 252, 10, 1217

    CrossRef

  12. 12
    Richard E Gonsette, A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis, Expert Opinion on Pharmacotherapy, 2004, 5, 4, 747

    CrossRef

  13. 13
    R.E Gonsette, Mitoxantrone in progressive multiple sclerosis: when and how to treat?, Journal of the Neurological Sciences, 2003, 206, 2, 203

    CrossRef

  14. 14
    Filippo Martinelli Boneschi, Marco Rovaris, Ruggero Capra, Giancarlo Comi, Mitoxantrone for multiple sclerosis, The Cochrane Library,
  15. 15
    Filippo Martinelli Boneschi, Laura Vacchi, Marco Rovaris, Ruggero Capra, Giancarlo Comi, Mitoxantrone for multiple sclerosis, The Cochrane Library,